This page contains a Flash digital edition of a book.
FIGURE 3. Catch-up immunization schedule for persons aged 4 months through 18 years who start late or who are more than 1 month behind —  does not need to be restarted, regardless of the time that has elapsed between doses. Use the section appropriate for the child’s age. Always use this table in conjunction with the accompanying childhood and adolescent immunization schedules (Figures 1 and 2) and their respective footnotes.


Persons aged 4 months through 6 years Vaccine Hepatitis B Rotavirus1 Diphtheria, tetanus, pertussis2


Minimum Age for Dose 1


Birth


6 weeks 6 weeks


 type b3


Dose 1 to dose 2 4 weeks


4 weeks 4 weeks


6 weeks


 


4 weeks 


 No further doses needed


 4 weeks Pneumococcal4 6 weeks


  age 24 through 59 months


 age 24 months or older


No further doses needed Inactivated poliovirus5 Meningococcal6


Measles, mumps, rubella7 Varicella8 Hepatitis A


6 weeks


9 months 12 months 12 months 12 months


4 weeks


8 weeks6 4 weeks 3 months 6 months


Persons aged 7 through 18 years


Tetanus, diphtheria/ tetanus, diphtheria, pertussis9


Human papillomavirus10 Hepatitis A


Hepatitis B


Inactivated poliovirus5 Meningococcal6


Measles, mumps, rubella7 Varicella8 7 years9 9 years 12 months Birth


6 weeks 9 months 12 months


12 months 6 months 4 weeks


if person is younger than age 13 years 4 weeks


4 weeks 8 weeks6 4 weeks 3 months


if person is aged 13 years or older


1. Rotavirus (RV) vaccines (RV-1 [Rotarix] and RV-5 [Rota Teq]).    initiated for infants aged 15 weeks, 0 days or older.


5. Inactivated poliovirus vaccine (IPV).  A fourth dose is not necessary if the third dose was administered at age 4 years or older and at least 6 months after the previous dose.


  indicated.


2. Diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine.   years or older.


3. type b (Hib) conjugate vaccine.  Hib vaccine should be considered for unvaccinated persons aged 5 years or  (HIV) infection, or anatomic/functional asplenia.


   be administered at age 12 through 15 months and at least 8 weeks after the second dose.


 4 weeks5


8 weeks 6 months5 4 weeks


 Routine dosing intervals are recommended10


 6 months


4 weeks


 younger than age 12 months


6 months


 


Minimum Interval Between Doses Dose 2 to dose 3 8 weeks


 administered at younger than age 12 months and second dose administered at younger than 15 months


if current age is younger than 12 months 3


4 weeks1 4 weeks 4 weeks3


if previous dose administered at age 15 months or older No further doses needed if current age is younger than 12 months 4 weeks


for healthy children if previous dose administered at age 24 months or older


 if current age is 12 months or older No further doses needed


4 weeks


 This dose only necessary for children aged 12 months through 59 months who received 3 doses before age 12 months or for children at high risk who received 3 doses at any age


minimum age 4 years for 


6 months5 6 months


 This dose only necessary for children aged 12 months through 59 months who received 3 doses before age 12 months


6 months2 Dose 3 to dose 4 Dose 4 to dose 5


6. Meningococcal conjugate vaccines, quadrivalent (MCV4). (Minimum age:   See Figure 1 (“Recommended immunization schedule for persons aged 0 through 6 years”) and Figure 2 (“Recommended immunization schedule for persons aged 7 through 18 years”) for further guidance.


7. Measles, mumps, and rubella (MMR) vaccine.  Administer the second dose routinely at age 4 through 6 years.


4. Pneumococcal vaccines. (Minimum age: 6 weeks for pneumococcal conjugate   For children aged 24 through 71 months with underlying medical conditions, administer 1 dose of PCV if 3 doses of PCV were received previously, or administer 2 doses of PCV at least 8 weeks apart if fewer than 3 doses of PCV were received previously.


 Administer PPSV to children aged 2 years or older with certain underlying medical conditions. See MMWR 2010:59(No. RR-11), available at http:// www.cdc.gov/mmwr/pdf/rr/rr5911.pdf.


   months.


8. Varicella (VAR) vaccine.  Administer the second dose routinely at age 4 through 6 years. If the  accepted as valid.


9. Tetanus and diphtheria toxoids (Td) and tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccines.  For children aged 7 through 10 years who are not fully immunized with the childhood DTaP vaccine series, Tdap vaccine should be substituted for  needed, use Td vaccine. For these children, an adolescent Tdap vaccine dose should not be given.


 A single dose of PCV may be administered to certain children aged 6 through 18 


 An inadvertent dose of DTaP vaccine administered to children aged 7 through 10 years can count as part of the catch-up series. This dose can count as the adolescent Tdap dose, or the child can later receive a Tdap booster dose at age 11–12 years.


10. Human papillomavirus (HPV) vaccines (HPV4 [Gardasil] and HPV2 [Cervarix]).  Administer the vaccine series to females (either HPV2 or HPV4) and males (HPV4) at age 13 through 18 years if patient is not previously vaccinated.


  2 (“Recommended immunization schedule for persons aged 7 through 18 years”).


http://www.vaers.hhs.gov) or by telephone (800-822-7967). Suspected cases of vaccine-preventable diseases should be reported to the state or local health department. Additional information, including precautions and contraindications for vaccination, is available from CDC online (http://www.cdc.gov/vaccines) or by telephone (800-CDC-INFO [800-232-4636]).


  recommended if the person is at risk for imminent exposure to circulating poliovirus (i.e., travel to a polio-endemic region or during an outbreak).  IPV is not routinely recommended for U.S. residents aged 18 years or older.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124